| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |